B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

HPRT1

MOLECULAR TARGET

hypoxanthine phosphoribosyltransferase 1

UniProt: P00492NCBI Gene: 32513 compounds

HPRT1 (hypoxanthine phosphoribosyltransferase 1) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting HPRT1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1guanine1.102
2Guanosine Monophosphate1.102
3Inosine Monophosphate Inosine 5'-Monophosphate.0.691

About HPRT1 as a Drug Target

HPRT1 (hypoxanthine phosphoribosyltransferase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented HPRT1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

HPRT1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.